Jay Formulations Ltd - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 1988.
1988 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Jay Formulations Ltd

Jay Formulations Ltd, a active public limited company, was established on 15 June 1988 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U17119GJ1988PLC010855. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.05 Cr and a paid-up capital of ₹2.00 Cr.

Formerly known as Bhavik Textiles Pvt Ltd. It upholds a compliant status. Its leadership includes Hemant Bhogilal Mehta (Additional Director), Hitendra Nihalchand Mehta (Additional Director), Darshan Bhogilal Mehta (Additional Director). Past directors included Maheshbhai Jivrambhai Patel, Rakshit Ashwinbhai Patel, Komal Rakshit Patel. It holds ₹73.81 Cr open charges and ₹1.30 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 13 First Floor Harikrishnacomplex B/H Dipalee Cinema Ashram Road, Ahmedabad, Gujarat, 380009.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U17119GJ1988PLC010855

  • Registration Number

    010855

  • Incorporation Date

    15 June 1988

  • Authorized Capital

    ₹3.05 Cr

  • Paid-Up Capital

    ₹2.00 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 3.05 Cr
  • Paid Up Capital ₹ 2.00 Cr
  • Company Age 37 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 73.81 Cr
  • Satisfied Charges ₹ 1.30 M
  • Revenue Growth **** 10.63%
  • Profit Growth **** -1694.28%
  • Ebitda **** -326.73%
  • Net Worth -115.25%
  • Total Assets -5.77%
Company report

Jay Formulations Ltd

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Jay Formulations Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Jay Formulations Ltd?
Current Directors
Name Designation Appointment Date Status
Hemant Bhogilal Mehta Additional Director 05 May 2025 Current
Hitendra Nihalchand Mehta Additional Director 05 May 2025 Current
Darshan Bhogilal Mehta Additional Director 05 May 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 31 Jul 2014 Past
Pramod Abcsdd Director 01 Jul 2013 Past
Pramod Abcsdd Additional Director 23 Dec 2019 Past
Pramod Abcsdd Irp/Rp/Liquidator 16 Jun 2025 Past
Pramod Abcsdd Director 17 Jun 2013 Past
Pramod Abcsdd Director 12 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Jay Formulations.

Jay Formulations Ltd, for the financial year ended 2021, experienced significant growth in revenue, with a 10.63% increase. The company also saw a substantial fall in profitability, with a 1694.28% decrease in profit. The company's net worth observed a substantial decline by a decrease of 115.25%.

Jay Formulations revenue growth over time
Jay Formulations profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 10.63%
*******
*******
*******
*******
Revenue from Operations
*******
 10.16%
*******
*******
*******
*******
Total Assets
*******
 -5.77%
*******
*******
*******
*******
Profit or Loss
*******
 -1694.28%
*******
*******
*******
*******
Net Worth
*******
 -115.25%
*******
*******
*******
*******
EBITDA
*******
 -326.73%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Jay Formulations?

In 2019, Jay Formulations had a promoter holding of 58.96% and a public holding of 41.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹738,064,977.00

Satisfied Charges

₹1,300,000.00

Charges Breakdown by Lending Institutions
  • State Bank Of India : 63.00 Cr
  • Sidbi : 7.80 Cr
  • Tata Capital Financial Services Limited : 1.24 Cr
  • The State Bank Of India : 0.89 Cr
  • Others : 0.88 Cr
Latest Charge Details
Date Lender Amount Status
08 Jan 2021 Sidbi ₹2.80 Cr Open
02 Jan 2021 Tata Capital Financial Services Limited ₹1.24 Cr Open
08 Sep 2020 Others ₹1.25 M Open
30 Jul 2020 Others ₹1.24 M Open
24 Jul 2020 Sidbi ₹2.80 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Jay Formulations?

Unlock and access historical data on people associated with Jay Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Jay Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jay Formulations's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Jay Formulations
Recent Activity within the Organization
  • Director Appointment

    Progress on Hemant Bhogilal Mehta was appointed as a Additional Director was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 10 months 23 days . was documented.

  • Director Appointment

    Progress on Hitendra Nihalchand Mehta was appointed as a Additional Director was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 10 months 23 days . was documented.

  • Director Appointment

    The activity Darshan Bhogilal Mehta was appointed as a Additional Director was appointed as a Additional Director on 05 May 2025 & has been associated with this company since 10 months 23 days . was completed.

  • Annual General Meeting

    Progress on Jay Formulations Ltd last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Progress on Jay Formulations Ltd has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was documented.

  • Charges

    The activity A charge with Sidbi amounted to Rs. 2.80 Cr with Charge ID 100406695 was registered on 08 Jan 2021. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Jay Formulations Ltd?

The CIN of Jay Formulations Ltd is U17119GJ1988PLC010855.

Where is Jay Formulations Ltd headquartered?

Jay Formulations Ltd is headquartered at 13 First Floor Harikrishnacomplex B/H Dipalee Cinema Ashram Road, Ahmedabad, Gujarat, 380009.

When was Jay Formulations Ltd incorporated?

Jay Formulations Ltd was incorporated on 15 June 1988.

Who are the current directors of Jay Formulations Ltd?

The current directors of Jay Formulations Ltd are

What is the primary industry of Jay Formulations Ltd?

The primary industry of Jay Formulations Ltd is Manufacturing.

Is Jay Formulations Ltd a listed company?

Jay Formulations Ltd is unlisted.

What is the capital structure of Jay Formulations Ltd?

The authorized capital of Jay Formulations Ltd is ₹3.05 Cr, and the paid-up capital is ₹2.00 Cr.

What is the compliance status of Jay Formulations Ltd?

The compliance status of Jay Formulations Ltd is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available